Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 6—June 2025
Research Letter

Nosocomial Transmission of Plasmodium falciparum Malaria, Spain, 2024

Manuel F. Liroa Romero, Maite Ruiz Pérez de Pipaón, Maria D. Navarro Amuedo, Jose M. Rubio Muñoz, Jose M. Jiménez-Hoyuela, and Jose M. CisnerosComments to Author 
Author affiliation: University of Seville, Seville, Spain (M.F. Liroa Romero, M. Ruiz Pérez de Pipaón, M.D. Navarro Amuedo, J.M. Jiménez-Hoyuela, J.M. Cisneros); Hospital Universitario Virgen del Rocío, Seville (M.F. Liroa Romero, M. Ruiz Pérez de Pipaón, M.D. Navarro Amuedo, J.M. Jiménez-Hoyuela, J.M. Cisneros); CIBERINFEC Instituto de Salud Carlos III, Madrid, Spain (J.M. Rubio Muñoz, J.M. Cisneros)

Main Article

Figure 2

Syringe covered with a lead shield used during nosocomial transmission of Plasmodium falciparum Malaria, Spain, 2024. A) Yellow lead shield with removable disposable syringe and needle. B) Syringe assembled with the lead shield.

Figure 2. Syringe covered with a lead shield used during nosocomial transmission of Plasmodium falciparum Malaria, Spain, 2024. A) Yellow lead shield with removable disposable syringe and needle. B) Syringe assembled with the lead shield.

Main Article

Page created: April 16, 2025
Page updated: May 07, 2025
Page reviewed: May 07, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external